At just 18, Finlay Anderson has already achieved so much. Preparing to embark on a new academic journey at the University of Edinburgh to study Law, Finlay’s path has been paved with dedication to advocacy and volunteerism, which he began navigating from a young age after losing his sight.
The Royal National Institute of Blind People (RNIB) is launching the development of a landmark set of guidelines and framework to help low vision clinics provide best practice care, which it will unveil today at a launch event at its state-of-the-art Low Vision Centre in the charity’s headquarters in London.
This study was undertaken to explore the experience of living with VKC. Nine families were interviewed – paired interviews with patients and parents using semi-structured approaches (May-October 2018). Interviews continued until data saturation was reached with no new information. The...
This retrospective research study aimed to investigate the evolution of glial proliferation of varying grades after successful idiopathic macular hole repair and its effects on foveal microstructure and best-corrected visual acuity (BCVA). Two-hundred and two eyes were enrolled in this...
Organisers of the UK’s largest optical event, 100% Optical, have announced the official exhibitor list which features top independents, returning names and brands that will be making their 100% Optical debut at the 2026 show. New eyewear and eyecare brands...
Once again, OCULUS brought the 'Vision Olympics' to the German Down Syndrome Sports Festival in Wetzlar. Participants had the opportunity to have their vision tested and receive a brief screening of the anterior segment of their eyes. This year, the...
Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).
This study prospectively evaluated the use of ripasudil, a rho kinase inhibitor, in patients undergoing Descemet’s stripping only (DSO) without an endothelial graft for Fuch’s endothelial dystrophy (FED). Patients with dense central guttae limited to the central 5mm of the...